Found 16 matching trials
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma PHASE1 This study is being conducted to identify how much and how often pralatrexa...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies PHASE2 This study is to evaluate the effect of leucovorin in preventing or reducin...
Show More Learn More & Join Trial
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder PHASE2 The purpose of this study is to determine whether pralatrexate, given with ...
Show More Location
The University of Arizona Health Sciences Center
Learn More & Join Trial
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment PHASE2 The purpose of this clinical study is to determine the effectiveness (abili...
Show More Location
Comprehensive Blood and Cancer Center
Learn More & Join Trial
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma PHASE1 This study is designed to determine the recommended dose, safety, pharmacok...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma PHASE2 Primary
• Determine the efficacy of pralatrexate with concurrent vitamin B...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) PHASE1 The purpose of this study is to evaluate the Maximum Tolerated Dose (MTD) o...
Show More Learn More & Join Trial
Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients PHASE3 The purpose of this study is to see if pralatrexate extends response and su...
Show More Location
Detroit Clinical Research Center, PC
Learn More & Join Trial
Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma PHASE2 The purpose of this study is to determine whether pralatrexate, given with ...
Show More Location
Tower Cancer Research Foundation
Learn More & Join Trial
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment PHASE1 This purpose of this study is to help to evaluate the pharmacokinetic (PK) ...
Show More Location
TOI Clinical Research
Learn More & Join Trial